RCS - Oxford Nanopore Tech - Upcoming Investor Events and Conferences

Oxford Nanopore TechnologiesAnnouncement

Wed 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260107:nRSG8477Na&default-theme=true

RNS Number : 8477N  Oxford Nanopore Technologies plc  07 January 2026

Oxford Nanopore Technologies plc

("Oxford Nanopore" or the "Company")

Oxford Nanopore to participate in upcoming investor conferences

07 January 2026

 

Oxford Nanopore Technologies plc (LSE: ONT), the company delivering a new
generation of molecular sensing technology based on nanopores, will be
participating in the following investor conferences in January.

 

·      44th Annual J.P. Morgan Healthcare Conference, San Francisco

Format: Presentation and Q&A session and investor meetings

Date: Monday, 12 January

Time: 2:15pm PT (5:15pm EST/10:15pm GMT)

Webcast: click here to register
(https://jpmorgan.metameetings.net/events/healthcare26/sessions/317526-oxford-nanopore-technologies-plc/webcast?gpu_only=true&kiosk=true)

 

·      dbAccess UK & Ireland Conference, London

Format: One-on-one and group investor meetings

Date: Tuesday, 20 January

 

A live webcast of the J.P. Morgan presentation and Q&A can be accessed at
the Company's investor relations page at:
https://nanoporetech.com/about/investors/reports
(https://nanoporetech.com/about/investors/reports) . A webcast replay will be
available for at least 30 days following the event via the same link.

 

-ENDS-

 

For further information, please contact:

Oxford Nanopore Technologies plc

Investors:        ir@nanoporetech.com (mailto:ir@nanoporetech.com)

Media:             media@nanoporetech.com
(mailto:media@nanoporetech.com)

 

Teneo (communications adviser to the Company)

Tom Murray, Lisa Jarrett-Kerr

+44 (0) 20 7353 4200

OxfordNanoporeTechnologies@teneo.com
(mailto:OxfordNanoporeTechnologies@teneo.com)

 

About Oxford Nanopore Technologies plc:

Oxford Nanopore Technologies' goal is to bring the widest benefits to society
through enabling the analysis of anything, by anyone, anywhere. The Group has
developed a new generation of nanopore-based sensing technology that is
currently used for real-time, high-performance, accessible, and scalable
analysis of DNA and RNA. The technology is used in more than 125 countries, to
understand the biology of humans, plants, animals, bacteria, viruses and
environments as well as to understand diseases such as cancer.  Oxford
Nanopore's technology also has the potential to provide broad, high impact,
rapid insights in a number of areas including healthcare, food and
agriculture.

For more information please visit: www.nanoporetech.com
(http://www.nanoporetech.com/)

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRABFMBTMTAMBFF



            Copyright 2019 Regulatory News Service, all rights reserved